156 related articles for article (PubMed ID: 36463240)
1. Novel blood-based FUT7 DNA methylation is associated with lung cancer: especially for lung squamous cell carcinoma.
Fang Y; Qu Y; Ji L; Sun H; Li J; Zhao Y; Liang F; Wang Z; Su J; Liu J; Dai L; Ouyang S
Clin Epigenetics; 2022 Dec; 14(1):167. PubMed ID: 36463240
[TBL] [Abstract][Full Text] [Related]
2. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.
Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S
Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401
[TBL] [Abstract][Full Text] [Related]
3. Identification of FUT7 hypomethylation as the blood biomarker in the prediction of early-stage lung cancer.
Qiao R; Di F; Wang J; Wei Y; Xu T; Dai L; Gu W; Han B; Yang R
J Genet Genomics; 2023 Aug; 50(8):573-581. PubMed ID: 36898609
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key DNA methylation sites related to differentially expressed genes in Lung squamous cell carcinoma.
Gao J; Feng Y; Yang Y; Shi Y; Liu J; Lin H; Zhang L
Comput Biol Med; 2023 Dec; 167():107615. PubMed ID: 37918267
[TBL] [Abstract][Full Text] [Related]
5. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
6.
Li M; Qiao R; Zhong R; Wei Y; Wang J; Zhang Z; Wang L; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Biomarkers; 2022 Feb; 27(1):79-85. PubMed ID: 34882057
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.
Zhu Q; Qiao R; Di F; Song Y; Zhang J; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Clin Chim Acta; 2022 Dec; 537():173-180. PubMed ID: 36332669
[TBL] [Abstract][Full Text] [Related]
8. The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case-Control Cohort.
Qiao R; Di F; Wang J; Wei Y; Zhang Y; Xu T; Wang Y; Gu W; Han B; Yang R
Cancer Manag Res; 2020; 12():11063-11075. PubMed ID: 33173339
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk.
Qiao R; Zhu Q; Di F; Liu C; Song Y; Zhang J; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Mol Carcinog; 2023 Nov; 62(11):1745-1754. PubMed ID: 37530470
[TBL] [Abstract][Full Text] [Related]
10. Survival-associated N
Qu J; Wang L; Jiang M; Wei Z; Fu G; Zhang X
BMC Cancer; 2021 Nov; 21(1):1265. PubMed ID: 34814861
[TBL] [Abstract][Full Text] [Related]
11. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of
Wang HL; Li KZ; Li JL; Hu BL
Biomark Med; 2020 May; 14(7):503-512. PubMed ID: 32208871
[No Abstract] [Full Text] [Related]
13. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
[TBL] [Abstract][Full Text] [Related]
14. The Association Between
Qiao R; Li M; Zhong R; Wei Y; Wang J; Zhang Z; Wang L; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Cancer Manag Res; 2021; 13():7919-7927. PubMed ID: 34703313
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
Lee N; Xia X; Meng H; Zhu W; Wang X; Zhang T; Zhang C; Zhang J; Luo P
Cancer Biomark; 2021; 30(1):63-73. PubMed ID: 32924987
[TBL] [Abstract][Full Text] [Related]
16. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
17. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
19. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K
J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
